Women's Health - Omnia Education

Episodes 17-25 of 25

Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey
Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey
CME/CE
Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey
0.50 credits
- Lee P. Shulman, MD, FACMG, FACOG
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- Sawsan As-Sanie, MD
0.50 credits
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
MinuteCE®
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
1.75 program credits
- Lee P. Shulman, MD, FACMG, FACOG
- Linda Bradley, MD
- Samantha Denäe
1.75 program credits
Case in Point: The Use of GnRH Antagonists Pre- and/or Post-Surgery and the Potential Consequences of Repeat Surgery
Case in Point: The Use of GnRH Antagonists Pre- and/or Post-Surgery and the Potential Consequences of Repeat Surgery
CME/CE
Case in Point: The Use of GnRH Antagonists Pre- and/or Post-Surgery and the Potential Consequences of Repeat Surgery
0.50 credits
- Lee P. Shulman, MD, FACMG, FACOG
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- James A. Simon, MD, CCD, NCMP, IF, FACOG
0.50 credits
Consensus Recommendations for Use of p16/Ki-67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV
Consensus Recommendations for Use of p16/Ki-67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV
CME/CE
Consensus Recommendations for Use of p16/Ki-67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV
0.25 credits
- Warner K. Huh, MD
- Kimberly Levinson, MD, MPH
0.25 credits
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
CME/CE
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
- Lee P. Shulman, MD, FACMG, FACOG
- Alexandra Benachi, MD, PhD
- Julien Zuber, MD, PhD
Alloimmune Neutropenia of the Fetus and Newborn
Alloimmune Neutropenia of the Fetus and Newborn
CME/CE
Alloimmune Neutropenia of the Fetus and Newborn
- Lee P. Shulman, MD, FACMG, FACOG
- Masja de Haas, MD, PhD
Alloimmune Thrombocytopenia in the Fetus and Newborn
Alloimmune Thrombocytopenia in the Fetus and Newborn
CME/CE
Alloimmune Thrombocytopenia in the Fetus and Newborn
0.25 credits
- Lee P. Shulman, MD, FACMG, FACOG
- James B. Bussel, MD
0.25 credits
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
CME/CE
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
- Lee P. Shulman, MD, FACMG, FACOG
- Kenneth J. Moise Jr., MD
Red Blood Cell Alloimmunization, Pathophysiology, Diagnosis, Treatment, and Prevention
Red Blood Cell Alloimmunization, Pathophysiology, Diagnosis, Treatment, and Prevention
CME/CE
Red Blood Cell Alloimmunization, Pathophysiology, Diagnosis, Treatment, and Prevention
- Lee P. Shulman, MD, FACMG, FACOG
- Kenneth J. Moise Jr., MD

Previous
1
2
Next

2/2